Literature DB >> 7683692

A mutation of the glucocorticoid receptor in primary cortisol resistance.

D M Malchoff1, A Brufsky, G Reardon, P McDermott, E C Javier, C H Bergh, D Rowe, C D Malchoff.   

Abstract

The precise molecular abnormalities that cause primary cortisol resistance have not been completely described. In a subject with primary cortisol resistance we have observed glucocorticoid receptors (hGR) with a decreased affinity for dexamethasone. We hypothesize that a mutation of the hGR glucocorticoid-binding domain is the cause of cortisol resistance. Total RNA isolated from the index subject's mononuclear leukocytes was used to produce first strand hGR cDNAs, and the entire hGR cDNA was amplified in segments and sequenced. At nucleotide 2,317 we identified a homozygous A for G point mutation that predicts an isoleucine (ATT) for valine (GTT) substitution at amino acid 729. When the wild-type hGR and hGR-Ile 729 were expressed in COS-1 cells and assayed for [3H]-Dexamethasone binding, the dissociation constants were 0.799 +/- 0.068 and 1.54 +/- 0.06 nM (mean +/- SEM) (P < 0.01), respectively. When the wild-type hGR and hGR-Ile 729 were expressed in CV-1 cells that were cotransfected with the mouse mammary tumor virus long terminal repeat fused to the chloramphenicol acetyl transferase (CAT) gene, the hGR-Ile 729 conferred a fourfold decrease in apparent potency on dexamethasone stimulation of CAT activity. The isoleucine for valine substitution at amino acid 729 impairs the function of the hGR and is the likely cause of primary cortisol resistance in this subject.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7683692      PMCID: PMC288186          DOI: 10.1172/JCI116410

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Primary cortisol resistance presenting as isosexual precocity.

Authors:  C D Malchoff; E C Javier; D M Malchoff; T Martin; A Rogol; D Brandon; D L Loriaux; G E Reardon
Journal:  J Clin Endocrinol Metab       Date:  1990-02       Impact factor: 5.958

2.  The genomic structure of the human glucocorticoid receptor.

Authors:  I J Encío; S D Detera-Wadleigh
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

3.  A movable and regulable inactivation function within the steroid binding domain of the glucocorticoid receptor.

Authors:  D Picard; S J Salser; K R Yamamoto
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

4.  Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor.

Authors:  S E Fawell; J A Lees; R White; M G Parker
Journal:  Cell       Date:  1990-03-23       Impact factor: 41.582

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

7.  A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.

Authors:  S J Usala; G E Tennyson; A E Bale; R W Lash; N Gesundheit; F E Wondisford; D Accili; P Hauser; B D Weintraub
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

8.  Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance.

Authors:  D M Hurley; D Accili; C A Stratakis; M Karl; N Vamvakopoulos; E Rorer; K Constantine; S I Taylor; G P Chrousos
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

9.  Cortisol receptor resistance: the variability of its clinical presentation and response to treatment.

Authors:  S W Lamberts; J W Koper; P Biemond; F H den Holder; F H de Jong
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

10.  Spontaneous hypercortisolism without Cushing's syndrome.

Authors:  A C Vingerhoeds; J H Thijssen; F Schwarz
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

View more
  21 in total

Review 1.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 2.  Chrousos syndrome: a seminal report, a phylogenetic enigma and the clinical implications of glucocorticoid signalling changes.

Authors:  Evangelia Charmandari; Tomoshige Kino
Journal:  Eur J Clin Invest       Date:  2010-08-19       Impact factor: 4.686

Review 3.  Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder.

Authors:  Evangelia Charmandari; Tomoshige Kino; Takamasa Ichijo; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2008-03-04       Impact factor: 5.958

4.  Glucocorticoid receptor mutants demonstrate increased motility inside the nucleus of living cells: time of fluorescence recovery after photobleaching (FRAP) is an integrated measure of receptor function.

Authors:  Tomoshige Kino; Szu-Heng Liou; Evangelia Charmandari; George P Chrousos
Journal:  Mol Med       Date:  2004 Jul-Dec       Impact factor: 6.354

Review 5.  Glucocorticoid and mineralocorticoid resistance.

Authors:  P A Komesaroff; M C Zennaro
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

6.  Human small cell lung cancer cell lines expressing the proopiomelanocortin gene have aberrant glucocorticoid receptor function.

Authors:  D W Ray; A C Littlewood; A J Clark; J R Davis; A White
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

7.  Structural Analysis on the Pathologic Mutant Glucocorticoid Receptor Ligand-Binding Domains.

Authors:  Darrell E Hurt; Shigeru Suzuki; Takafumi Mayama; Evangelia Charmandari; Tomoshige Kino
Journal:  Mol Endocrinol       Date:  2016-01-08

8.  Dissecting the human plasma proteome and inflammatory response biomarkers.

Authors:  Sudipto Saha; Scott H Harrison; Jake Yue Chen
Journal:  Proteomics       Date:  2009-01       Impact factor: 3.984

Review 9.  The human glucocorticoid receptor: molecular basis of biologic function.

Authors:  Nicolas C Nicolaides; Zoi Galata; Tomoshige Kino; George P Chrousos; Evangelia Charmandari
Journal:  Steroids       Date:  2009-10-07       Impact factor: 2.668

Review 10.  Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity.

Authors:  Evangelia Charmandari; Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2013-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.